A little bit off-IMU-topic but could become relevant one day,
PH seems to target fighting cancer with PD-L1 technologies from different angles, here the latest RAD anns:
Radiopharm will shortly initiate a PD-L1 Phase 1 therapeutic study in Australia in patients
with NSCLC
• Radiopharm acquired from NanoMab, Ltd. worldwide rights to PD-L1 technology for
therapeutic use, as well as to imaging rights in China
Looking at all the licences from IMU, CHM and RAD the puzzle pieces slowly turn into a broad spectrum picture with the 3 comps individually contributing. He is like conductor leading a big modern orchestra.
GLTA
A little bit off-IMU-topic but could become relevant one day,PH...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.9¢ |
Change
-0.004(4.82%) |
Mkt cap ! $578.2M | |||
| Open | High | Low | Value | Volume |
| 8.2¢ | 8.3¢ | 7.7¢ | $1.357M | 17.06M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 735848 | 7.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.0¢ | 328052 | 7 |
View Market Depth
| Last trade - 16.10pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
8.0¢ |
Change
-0.004 ( 4.33 %) |
||||
| Open | High | Low | Volume | ||
| 8.2¢ | 8.2¢ | 7.8¢ | 7785002 | ||
| Last updated 15.59pm 26/04/2024 ? | |||||
| IMU (ASX) Chart |